83 related articles for article (PubMed ID: 1806275)
1. Synthesis and biological activity of 11-[4-(cinnamyl)-1-piperazinyl]- 6,11-dihydrodibenz[b,e]oxepin derivatives, potential agents for the treatment of cerebrovascular disorders.
Kurokawa M; Sato F; Masuda Y; Yoshida T; Ochi Y; Zushi K; Fujiwara I; Naruto S; Uno H; Matsumoto J
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2564-73. PubMed ID: 1806275
[TBL] [Abstract][Full Text] [Related]
2. A new series of antiallergic agents. II. Synthesis and activity of new 6,11-dihydrodibenz[b,e]oxepin-carboxylic acid derivatives.
Kumazawa T; Ohshima E; Harakawa H; Sato H; Obase H; Oiji Y; Ishii A; Ishii H; Ohmori K
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2729-33. PubMed ID: 1687211
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
[TBL] [Abstract][Full Text] [Related]
4. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivatives.
Ohshima E; Otaki S; Sato H; Kumazawa T; Obase H; Ishii A; Ishii H; Ohmori K; Hirayama N
J Med Chem; 1992 May; 35(11):2074-84. PubMed ID: 1350797
[TBL] [Abstract][Full Text] [Related]
6. A new series of antiallergic agents. I. Synthesis and activity of 11-(2-aminoethyl)thio-6,11-dihydrodibenz[b,e]oxepin derivatives.
Ohshima E; Kumazawa T; Takizawa H; Harakawa H; Sato H; Obase H; Oiji Y; Ishii A; Ishii H; Ohmori K
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2724-8. PubMed ID: 1687210
[TBL] [Abstract][Full Text] [Related]
7. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal antiinflammatory agents. IV. Syntheses of pyridobenzoxepin, pyridobenzothiepin and their acetic acid derivatives.
Tagawa H; Kubo S; Ishikawa F
Chem Pharm Bull (Tokyo); 1981 Dec; 29(12):3515-21. PubMed ID: 7340945
[No Abstract] [Full Text] [Related]
9. Effect of (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11 -yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on cerebral vasospasm and impairment of cerebral circulation in subarachnoid hemorrhage model in rats.
Honda Y; Minato H; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1996 Aug; 46(8):746-50. PubMed ID: 9125271
[TBL] [Abstract][Full Text] [Related]
10. Cerebroprotective effect of flunarizine.
Nikolov R; Nikolova M; Dikova M; Mirzoyan RS; Ganshina TS; Volobueva TI
Methods Find Exp Clin Pharmacol; 1990; 12(6):411-8. PubMed ID: 2087140
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiulcer activity of 5,11-dihydro[1]benzoxepino[3,4-b]pyridines.
Kumazawa T; Harakawa H; Obase H; Oiji Y; Tanaka H; Shuto K; Ishii A; Oka T; Nakamizo N
J Med Chem; 1988 Apr; 31(4):779-85. PubMed ID: 3351856
[TBL] [Abstract][Full Text] [Related]
12. Effects of anticancer drugs, metals and antioxidants on cytotoxic activity of benzothiepins/benzoxepins.
Terasawa K; Hosoya H; Sugita Y; Yokoe I; Sakagami H
Anticancer Res; 2000; 20(5A):2951-4. PubMed ID: 11062706
[TBL] [Abstract][Full Text] [Related]
13. [Effects of flunarizine on chronic cerebrovascular insufficiency: experience of a geriatric department].
Ronchini P; D'Ambrosio E; Anesi E; Pellicioni P
G Clin Med; 1982 Feb; 63(2):131-9. PubMed ID: 7106462
[No Abstract] [Full Text] [Related]
14. Studies on cerebral protective agents. I. Novel 4-arylpyrimidine derivatives with anti-anoxic and anti-lipid peroxidation activities.
Kuno A; Sugiyama Y; Katsuta K; Kamitani T; Takasugi H
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1452-61. PubMed ID: 1394663
[TBL] [Abstract][Full Text] [Related]
15. Total synthesis of bulbophylol-B.
Lin J; Zhang W; Jiang N; Niu Z; Bao K; Zhang L; Liu D; Pan C; Yao X
J Nat Prod; 2008 Nov; 71(11):1938-41. PubMed ID: 18959443
[TBL] [Abstract][Full Text] [Related]
16. Studies on the synthesis of condensed pyridazine derivatives. IV. Synthesis and anxiolytic activity of 2-aryl-5,6-dihydro-(1)benzothiepino[5,4- c]pyridazin-3(2H)-ones and related compound.
Nakao T; Obata M; Kawakami M; Morita K; Tanaka H; Morimoto Y; Takehara S; Yakushiji T; Tahara T
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2556-63. PubMed ID: 1687209
[TBL] [Abstract][Full Text] [Related]
17. Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents. 1. 6,11-Dihydro-11-oxodibenz]b,e]oxepin-2-acetic acids.
Aultz DE; Helsley GC; Hoffman D; McFadden AR
J Med Chem; 1977 Jan; 20(1):66-70. PubMed ID: 833828
[TBL] [Abstract][Full Text] [Related]
18. Prevention by the new Ca2+ channel antagonist, AJ-3941, of loss of endothelium-dependent relaxation after subarachnoid hemorrhage in rats.
Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
Eur J Pharmacol; 1996 Nov; 315(3):297-303. PubMed ID: 8982668
[TBL] [Abstract][Full Text] [Related]
19. 1-[Ethoxyamino)methyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2-benzoxepins: a new class of antianaphylactic agents.
TenBrink RE; McCall JM; Johnson HG
J Med Chem; 1980 Sep; 23(9):1058-60. PubMed ID: 7411551
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE].
Devissaguet M
Presse Med; 1983 Mar; 12(13):823-9. PubMed ID: 6220330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
